Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2018

Open Access 01-12-2018 | Research

Canadian French translation and linguistic validation of the child health utility 9D (CHU9D)

Authors: Thomas G. Poder, Nathalie Carrier, Harriet Mead, Katherine J. Stevens

Published in: Health and Quality of Life Outcomes | Issue 1/2018

Login to get access

Abstract

Background

Several preference based measures are validated for adults in cost utility analysis, but less are available for children and many researchers have criticized the quality of pediatric economic studies. The objective of this study was to perform a Canadian French translation and linguistic validation of the Child Health Utility 9D (CHU9D) that was conceptually equivalent to the original English version for use in Canada.

Methods

The translation and linguistic validation were realized by ICON Clinical Research (UK) Limited in association with the developer of the CHU9D and Canadian collaborators. This was done in accordance with industry standards and the guidance of the Food and Drug Administration (FDA) for patient-reported outcome (PRO) instruments. Five steps were considered: concept elaboration; forward translation; back translation; linguistic validation; proofreading and final verification.

Results

The CHU9D Canadian French translation and linguistic validation were realized without any major difficulties. Only 3 changes were made after the forward translation and 5 after the back translation. The result of back translation was very similar to the original English version. Six additional changes suggested by the developer team were accepted and the linguistic validation with five children led to 2 additional changes. Most changes were generally to change one word to better sounding Canadian French.

Conclusion

We produced a Canadian French translation and cross-cultural adaptation of the Child Health Utility 9D (CHU9D). Before being used in clinical settings and research projects, the final Canadian French translation needs to be validated for metrological qualities of reliability and validity.
Appendix
Available only for authorised users
Literature
1.
Harris C, Green S, Ramsey W, Allen K, King R. Sustainability in health care by allocating resources effectively (SHARE) 1: introducing a series of papers reporting an investigation of disinvestment in a local healthcare setting. BMC Health Serv Res. 2017;17(1):323.CrossRefPubMedPubMedCentral
2.
Poder TG. Using the health technology assessment toolbox to facilitate procurement: the case of smart pumps in Canadian hospital. Int J Technol Assess Health Care. 2017;33(1):54–62.CrossRefPubMed
3.
Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care Programmes (4th edition). In: Oxford University press; 2015.
4.
5.
Fauteux V, Poder TG. État des lieux sur les méthodes d’élicitation du QALY [Overview of QALY elicitation methods]. Int J Health Preference Research. 2017;1:2–14.
6.
Brazier J, Ratcliffe J, Salomon JA, Tsuchiya A. Measuring and valuing health benefits for economic evaluation. In: Oxf Univ press; 2007.
7.
Chen G, Ratcliffe J. A review of the development and application of generic multi-attribute utility instruments for Paediatric populations. PharmacoEconomics. 2015;33(10):1013–28.CrossRefPubMed
8.
Griebsch I, Coast J, Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics. 2005;115(5):e600–14.CrossRefPubMed
9.
Ungar WJ. Paediatric health economic evaluations: a world view. Healthc Q Tor Ont. 2007;10(1):134–40. 142–5; discussion 145-146
10.
Ungar WJ. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated? PharmacoEconomics. 2011;29(8):641–52.CrossRefPubMed
11.
Wille N, Badia X, Bonsel G, Burström K, Cavrini G, Devlin N, et al. Development of the EQ-5D-Y: a child-friendly version of the EQ-5D. Qual Life Res. 2010;19(6):875–86.CrossRefPubMedPubMedCentral
12.
Moodie M, Richardson J, Rankin B, Iezzi A, Sinha K. Predicting time trade-off health state valuations of adolescents in four Pacific countries using the assessment of quality-of-life (AQoL-6D) instrument. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2010;13(8):1014–27.CrossRef
13.
Furlong WJ, Feeny DH, Torrance GW, Barr RD. The health utilities index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33(5):375–84.CrossRefPubMed
14.
Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q. Multiattribute utility function for a comprehensive health status classification system. Health utilities index mark 2. Med Care. 1996;34(7):702–22.CrossRefPubMed
15.
Nathan PC, Furlong W, Horsman J, Van Schaik C, Rolland M, Weitzman S, et al. Inter-observer agreement of a comprehensive health status classification system for pre-school children among patients with Wilms’ tumor or advanced neuroblastoma. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2004;13(10):1707–14.CrossRef
16.
Stevens K. Developing a descriptive system for a new preference-based measure of health-related quality of life for children. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2009;18(8):1105–13.CrossRef
17.
Stevens K. Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation. Appl Health Econ Health Policy. 2011;9(3):157–69.CrossRefPubMed
18.
19.
Apajasalo M, Rautonen J, Holmberg C, Sinkkonen J, Aalberg V, Pihko H, et al. Quality of life in pre-adolescence: a 17-dimensional health-related measure (17D). Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 1996;5(6):532–8.CrossRef
20.
Apajasalo M, Sintonen H, Holmberg C, Sinkkonen J, Aalberg V, Pihko H, et al. Quality of life in early adolescence: a sixteen-dimensional health-related measure (16D). Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 1996;5(2):205–11.CrossRef
21.
Szende A, Janssen B, Cabases J. Self-reported population health: an international perspective based on EQ-5D. In: Springer Netherlands; 2014.
22.
23.
Stevens KJ. Working with children to develop dimensions for a preference-based, generic, pediatric, health-related quality-of-life measure. Qual Health Res. 2010;20(3):340–51.CrossRefPubMed
24.
Wild D, Eremenco S, Mear I, Martin M, Houchin C, Gawlicki M, et al. Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR patient-reported outcomes translation and linguistic validation good research practices task force report. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2009;12(4):430–40.CrossRef
25.
Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2005;8(2):94–104.CrossRef
26.
Food and Drug Administration. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009.
27.
28.
Alda M, Minguez J, Montero-Marin J, Gili M, Puebla-Guedea M, Herrera-Mercadal P, et al. Validation of the Spanish version of the multidimensional state boredom scale (MSBS). Health Qual Life Outcomes. 2015;13:59.CrossRefPubMedPubMedCentral
29.
Montazeri A, Harirchi AM, Shariati M, Garmaroudi G, Ebadi M, Fateh A. The 12-item general health questionnaire (GHQ-12): translation and validation study of the Iranian version. Health Qual Life Outcomes. 2003;1:66.CrossRefPubMedPubMedCentral
30.
31.
Terwee CB, CAC P, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study. Qual Life Res. 2018;27(5):1159–70.CrossRefPubMedPubMedCentral
Metadata
Title
Canadian French translation and linguistic validation of the child health utility 9D (CHU9D)
Authors
Thomas G. Poder
Nathalie Carrier
Harriet Mead
Katherine J. Stevens
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2018
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-018-0998-4

Other articles of this Issue 1/2018

Health and Quality of Life Outcomes 1/2018 Go to the issue

Research

Fitness as mediator between weight status and dimensions of health-related quality of life

Research

Peer effects in health valuation: the relation between rating of contemporaries’ health and own health

Research

What were they thinking when providing preference measurements for generic health states? The evidence for HUI3

Research

Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study

Research

Quality of life and psychological distress in women with recurrent miscarriage: a comparative study

Review

A systematic review of the psychometric properties of the cross-cultural translations and adaptations of the Multidimensional Perceived Social Support Scale (MSPSS)